Rowan Gardner is a life science strategy and business development professional with a substantial network of investor contacts that participate in all stages of company creation and growth. As Head of Investor Relations at Oxford Molecular she developed and delivered the corporate communications, IR and PR strategies.

Rowan maintains close relationships with various industry groups such as Astia, and Digital Health Forum. She has consulted to various UK RDAs, SMEs and financial institutions to help broker, fund and develop new initiatives. Rowan has recently led projects to bring new venture and translational capital into the UK life sciences sector.